» Visit www.biopharminternational.com to utilize our upgraded search engine, view expanded topic coverage, experience multimedia content, access content archives, and more.
BIOPHARM INTERNATIONAL 2011 WEBCAST SERIES
BioPharm International is pleased to present its 2011 Web Seminar Series, addressing key issues in process development and bioprocessing. These one-hour sessions include presentations by industry experts and interactive dialogue with the audience. Watch live and participate in the Q&A, or catch them later on demand. |
|
| Webcasts: |
Single-Use Technologies: Establishing Quality Agreements
OnDemand Webcast
Supply chain security—important for all biopharmaceutical manufacturing— extends to single-use bioprocessing systems. End users want to ensure the quality of equipment, the consistency of materials, and the long-term security of supply for the lifetime of the drug. Yet purchase agreements can get bogged down as suppliers fulfill lengthy requests for information in formats customized for each user. Can quality agreements for single-use equipment be standardized? Here, speakers from industry and the Bio-Process Systems Alliance (BPSA), an alliance of suppliers and users of single-use equipment, discuss what both end users and suppliers would like to see in a template for quality agreements, and how different priorities can be met in a way that benefits all involved. Panelists will discuss the current initiative do develop such a template.
|
|
| Featured Webcast: |
Bio-G Webinar - Real-Time Scheduling of Biomanufacturing Supply Chains
Thursday, June 23, 2011. 1:00PM Pacific - Biomanufacturing Supply Chains are unique in their need to account for variability and risk in bulk, fill and packaging production and inventory positioning. We'll describe a different approach to biomanufacturing supply chain planning that optimizes inventory levels and risk strategies in real time. We'll show how by focusing on real-time data from PI, Delta V, Oracle, SAP, Excel and other sources, biomanufacturers can quickly re-plan against real-time events in seconds rather than hours or days.
|
|
A Conversation with BIO's Jim Greenwood
Jim Greenwood comments on the state of innovation in the bio/pharmaceutical industry and discusses policies that could help move promising technologies out of discovery and into development. Podcast interview by Editor Director Michelle Hoffman.
|
|
|
Answers to Your Questions about QbD
Hundreds of listeners tuned into our recent web seminar on Quality by Design, and we didn?t have time to answer all their questions. Fortunately, our speakers gathered to answer the common questions in this podcast. Listen to hear their views.
|
|
|
The Current State of Supply Chain Security: An FDA Perspective
In this interview, Richard L. Friedman, Director of the Division of Manufacturing & Product Quality in the Center for Drug Evaluation and Research, FDA's Office of Compliance discusses the progress made so far in executing supply chain security programs.
|
|
|
|
|
| New App Notes: |
Image Quality in Particle Analysis
This white paper documents how image quality affects the ability of imaging particle analyzers to produce accurate measurements and automatically recognize and classify different particles in a heterogeneous mixture.
| » More |
Advertiser: Fluid Imaging
|
|
|
Fluid Imaging Resolution, Sampling Considerations Resolution and Sampling Considerations for Accuracy in Imaging Particle Analysis
This paper explains how imaging particle analyzers measure size, shape and gray-scale information to automatically characterize different particles in a heterogeneous sample such as protein agglomerates from silicone droplets. Most other particle analyzers only offer a distribution of particle size. Consider these resolution and sampling basics for maximum success.
| » More |
Advertiser: Fluid Imaging
|
|
|
Purification of DNA-Based Oligonucleotide at 60ºC on TSKgel SuperQ-5PW (20)
This paper discusses the use of TSKgel SuperQ-5PW (20) for the purification of oligonucleotides. A gradient was selected and pH screening done at a temperature of 60ºC.
| » More |
Advertiser: Tosoh Bioscience
|
|
|
| Featured Whitepapers: |
Keys to reducing time-to-market
With development times measured in years, increasing costs represent a major challenge confronting pharmaceutical and biotechnology companies. As a result, reducing time-to-market is an essential component in any business strategy.
|
|
Finding the right contract manufacturer
With fewer blockbuster drugs in the pipeline, companies are on the lookout for an enduring
solution to meet market challenges. To maintain or expand market shares, pharmaceutical companies must devise new strategies to remain competitive.
|
